Filing Details
- Accession Number:
- 0001140361-12-016305
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-16 16:49:54
- Reporting Period:
- 2012-03-14
- Filing Date:
- 2012-03-16
- Accepted Time:
- 2012-03-16 16:49:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
930553 | Ista Pharmaceuticals Inc | ISTA | Pharmaceutical Preparations (2834) | 330511719 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
824468 | Ag/ Suisse Credit | See Footnote (1) In Exhibit 99.1 Eleven Madison Avenue New York NY 10010 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-03-14 | 28,571 | $8.70 | 4,908,153 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-03-15 | 130,256 | $8.58 | 4,777,897 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-03-15 | 157,043 | $8.58 | 4,620,854 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-03-15 | 145,573 | $8.52 | 4,475,281 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-03-15 | 4,373 | $8.59 | 4,470,908 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- See footnote (1) in Exhibit 99.1.
- See footnote (2) in Exhibit 99.1.
- See footnote (3) in Exhibit 99.1.
- See footnote (4) in Exhibit 99.1.
- See footnote (5) in Exhibit 99.1.
- See footnote (6) in Exhibit 99.1.
- See footnote (7) in Exhibit 99.1.
- See footnote (8) in Exhibit 99.1.
- See footnote (9) in Exhibit 99.1.
- See footnote (10) in Exhibit 99.1.
- See footnote (11) in Exhibit 99.1.